Objective: The aim of this study was to evaluate the functional characteristics of ArcCheck? array detectors and the application for Tomotherapy IMRT plan verification. Method and Materials: The basic character of the...Objective: The aim of this study was to evaluate the functional characteristics of ArcCheck? array detectors and the application for Tomotherapy IMRT plan verification. Method and Materials: The basic character of the ArcCheck applying on Tomotherapy system was tested. The diode testing procedures included the followings: The short term reproducibility, linearity, dose rate dependence, the profile measurement compared to ion chamber. The effect of insert on gamma passing rate was also studied. A total number of 602 Tomotherapy Delivery Quality Assurance (DQA) plans were retrospectively analyzed to obtain the action limit results with statistical significance evaluation. Results: The short term reproducibility, linearity, dose rate dependence, profile to ion chamber correlation and clinical application were all compared with satisfactory outcome with this device. If anterior diode points were properly calibrated with machine absolute output, then there was no significant difference between the ArcCheck phantom with and without insert on gamma passing rate. The average passing rate was 97.5% and the recommend action level was established at 92% based on the 602 patients’ clinical data with 95% confidence level criteria. Conclusion: This comprehensive study shows that ArcCheck is an accurate and efficient device for quality assurance of Tomotherapy with remarkable consistency of 3D volume analysis of arc therapy.展开更多
文摘Objective: The aim of this study was to evaluate the functional characteristics of ArcCheck? array detectors and the application for Tomotherapy IMRT plan verification. Method and Materials: The basic character of the ArcCheck applying on Tomotherapy system was tested. The diode testing procedures included the followings: The short term reproducibility, linearity, dose rate dependence, the profile measurement compared to ion chamber. The effect of insert on gamma passing rate was also studied. A total number of 602 Tomotherapy Delivery Quality Assurance (DQA) plans were retrospectively analyzed to obtain the action limit results with statistical significance evaluation. Results: The short term reproducibility, linearity, dose rate dependence, profile to ion chamber correlation and clinical application were all compared with satisfactory outcome with this device. If anterior diode points were properly calibrated with machine absolute output, then there was no significant difference between the ArcCheck phantom with and without insert on gamma passing rate. The average passing rate was 97.5% and the recommend action level was established at 92% based on the 602 patients’ clinical data with 95% confidence level criteria. Conclusion: This comprehensive study shows that ArcCheck is an accurate and efficient device for quality assurance of Tomotherapy with remarkable consistency of 3D volume analysis of arc therapy.
